The DOI matches its Crossref record; 115 of the 120 references it cites were found in a registry or an index; 164 of the 191 sources its claims cite were checked for support.
Research Advances in the Pathogenesis of Sepsis-Associated Encephalopathy
Open accessAbstract
Sepsis-associated encephalopathy (SAE) is a frequent neurological complication of sepsis, driven by six interconnected pathophysiological components: (1) systemic inflammation-triggered neuroinflammatory cascades, initiated by systemic recognition of pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) and propagated by pro-inflammatory mediators; (2) central nervous system (CNS) immune cell-mediated neuroinflammation, wherein microglia, regulatory T cells, and neutrophils dynamically regulate inflammatory progression; (3) blood-brain barrier (BBB) disruption, progressing from functional disturbance to structural damage via tight junction degradation and immune infiltration; (4) multimodal programmed cell death, encompassing autophagy, apoptosis, pyroptosis, and ferroptosis driven by mitochondrial dysfunction; (5) neurotransmitter network imbalance, manifesting as cholinergic deficiency and glutamate excitotoxicity; and (6) gut-brain axis dysregulation, characterized by reduced microbiota-derived metabolites such as butyrate and indolepropionic acid. These components are organized along a core pathological axis comprising four sequential stages: neuroinflammatory storm (encompassing components 1 and 2) → BBB disruption and microcirculatory disturbances (component 3) → multimodal programmed cell death (component 4) → neurotransmitter imbalance (component 5), with the gut-brain axis (component 6) functioning as a bidirectional regulatory node that intersects and modulates all four stages. Mitochondrial dysfunction serves as the central converging node linking these pathological axes. Targeted interventions against neuroinflammation, immune cell modulation, BBB restoration, inhibition of aberrant cell death, neurotransmitter homeostasis, and gut microbiota remodeling hold therapeutic promise. Elucidating the crosstalk among these pathways will accelerate the clinical translation of precision therapies for SAE.
Overview
CoChat Summary
TL;DR
This review synthesizes evidence on sepsis-associated encephalopathy (SAE) pathogenesis into six interconnected components organized along four sequential pathological axes, with mitochondrial dysfunction as the central converging node and the gut–brain axis as a bidirectional regulatory node. It classifies interventions by clinical translation stage and highlights major barriers to clinical translation.
Key findings
- SAE occurs in more than 50% of hospitalized sepsis patients; characteristic consciousness fluctuations are associated with a three- to fivefold higher risk of death, and in-hospital mortality reaches 45–60% in severe cases.
- The review proposes six components: neuroinflammatory cascades, CNS immune cell-mediated neuroinflammation, BBB disruption, multimodal programmed cell death (autophagy, apoptosis, pyroptosis, ferroptosis), neurotransmitter network imbalance, and gut–brain axis dysregulation. These are organized as neuroinflammatory storm → BBB disruption and microcirculatory disturbances → multimodal programmed cell death → neurotransmitter imbalance, with the gut–brain axis modulating all four axes and mitochondrial dysfunction as the central converging node.
- Cited clinical/preclinical data include: SAE patients show 2.3-fold and 1.8-fold increases in peripheral blood S100β and GFAP, respectively, positively correlated with MDA accumulation (r = 0.72), alongside a 40% decrease in SOD activity; SAE model mice show 62–75% decreases in SCFA-producing bacteria and 54–68% reductions in acetate and propionate; propofol combined with dexmedetomidine reduced FTH1 expression by 58% and MDA levels by 41%.
- Intervention strategies are classified by clinical translation stage—clinically available drugs, preclinical candidates, and potential molecular targets—with examples including NAC, oxytocin, fluoxetine, dexmedetomidine, α7nAChR agonists, FMT, and SCFA/propionate supplementation.
Methods
- Narrative review with a comprehensive literature search in PubMed, Web of Science, and Embase for studies published between January 2015 and March 2026, combining MeSH terms and free-text keywords; separate searches were conducted for each pathological component (neuroinflammation, BBB disruption, cell death, neurotransmitter imbalance, gut–brain axis).
- Inclusion criteria: English original research articles, reviews, or clinical studies investigating SAE pathogenesis involving neuroinflammatory cascades, BBB disruption, cell death pathways, or gut–brain axis dysregulation; interventional studies had to report clear mechanisms of action, and reviews were included if they systematically summarized relevant evidence. Exclusion criteria included case reports with fewer than 3 subjects, conference abstracts without full text, and non-peer-reviewed publications.
- Three-stage selection identified 2500 records, of which 380 underwent full-text review; ultimately 116 references were included in the primary analysis. Data were extracted and synthesized according to four core pathological components, and intervention strategies were critically classified by clinical translation stage.
Limitations
- The paper states that the proposed integrated pathological axis is established by synthesizing evidence from diverse study designs; most included studies are observational or associative rather than designed to verify causal relationships, so causal interactions among components remain to be validated.
- The paper states reproducibility concerns and model heterogeneity: LPS injection produces rapid, transient neuroinflammation whereas CLP induces polymicrobial sepsis with more sustained CNS pathology, yielding divergent cytokine profiles and microglial activation kinetics; rodent–human differences in microglial density, BBB tight junction composition, and cholinergic system organization restrict extrapolation. It also notes that SAE lacks standardized diagnostic criteria, animal models use young healthy mice and lack mechanical ventilation, sedation, and polypharmacy, and translational challenges include poor CNS penetration, timing mismatch between preclinical prophylaxis and clinical diagnosis, unvalidated biomarkers (NGAL, S100β, GFAP), and multi-target complexity.
- Evident from the text: as a narrative review, it does not report a systematic quantitative synthesis or meta-analysis, and no formal risk-of-bias assessment tool is described.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
122 Valid · 16 Not valid · 15 Not checked · 41 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“early activation exerts protective effects via Foxc1-mediated IκBα/NF-κB signaling regulation [16]”
§ Research Advances in the Pathogenesis of Sepsis-Associated Encephalopathy > 3. Pathogenesis and Therapeutic Strategies > 3.2. Immune Cell-Mediated Regulation of Neuroinflammation
What the sources say
- Disputedcites [16] Wang, 2022, Overexpression of Foxc1 ameliorates sepsis-associated encephalopathy by inhibiting microglial migration and neuroinflammation through the IκBα/NF-κB pathway, Mol. Med. Rep. sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) says Foxc1 overexpression prevented sepsis-induced neuroinflammation and microglial migration, likely through IκBα/NF-κB signaling. It does not present early microglial activation as protective; instead, it describes inflammatory microglial activation as contributing to neuronal damage. (LLM, conf=0.86)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“IRGM1 inhibits neuronal apoptosis and activates protective autophagy by regulating p38 MAPK phosphorylation [60], while sestrin 2 exerts therapeutic effects by enhancing autophagy via the ULK1 pathway [63].”
§ Research Advances in the Pathogenesis of Sepsis-Associated Encephalopathy > 3. Pathogenesis and Therapeutic Strategies > 3.4. MultiModal Programmed Cell Death Interaction Mechanisms
What the sources say
- Disputedcites [60] Zhou, 2020, Regulation of hippocampal neuronal apoptosis and autophagy in mice with sepsis-associated encephalopathy by immunity-related GTPase M1, CNS Neurosci. Ther. sourceExperimental — accuracy not yet measured
The Results report that SAE-induced neuronal apoptosis was lower in Irgm1-knockout mice than in wild-type mice. The Discussion concludes that increased IRGM1 activates p38 MAPK signaling, which then induces neuronal apoptosis—not that IRGM1 inhibits it. The cited passages do not specify phosphorylation as the mechanism. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Mitochondrial regulatory networks indicate that Nogo-A induces mitophagy and apoptosis via the ROS-p-SHP2 axis [64], while Omi/HtrA2 promotes apoptosis through dual mechanisms: inhibiting XIAP and inducing mitochondrial membrane potential depolarization [65].”
§ Research Advances in the Pathogenesis of Sepsis-Associated Encephalopathy > 3. Pathogenesis and Therapeutic Strategies > 3.4. MultiModal Programmed Cell Death Interaction Mechanisms
What the sources say
- Disputedcites [64] Liu, 2024, Nogo-A exacerbates sepsis-associated encephalopathy by modulating microglial SHP-2/NLRP3 balance and inducing ROS and M1 polarization, Biomol. Biomed. sourceExperimental — accuracy not yet measured
The Results section (‘In vivo western blot shows Nogo-A indirectly inhibits p-SHP2 expression’; page unavailable) says Nogo-A indirectly inhibits mitochondrial autophagy, rather than inducing mitophagy. The Discussion likewise says Nogo-A knockdown enhances mitochondrial autophagy. Although the paper links Nogo-A to ROS and apoptosis-related proteins, it contradicts the claim’s direction of effect on mitophagy. (LLM, conf=0.89)
Checked by a reasoning model — may be wrong.
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Second, therapeutic timing represents a critical disconnect—preclinical studies universally administer interventions prophylactically or within hours of insult, whereas clinical SAE is typically recognized after established pathology, potentially beyond the window for mechanism-based intervention.”
§ Research Advances in the Pathogenesis of Sepsis-Associated Encephalopathy > 4. Integrated Discussion and Critical Appraisal > 4.1. Synthesis of the Core Pathological Axis
What the sources say
- Disputedcites [3] Zhang, 2025, Integrated multi omics and machine learning reveal mitochondrial immunometabolic networks in sepsis associated encephalopathy, Sci. Rep. sourceExperimental — accuracy not yet measured
In “Animal maintaining” (page unavailable), the paper reports administering mtDNA or PBS to rats 24 hours after modeling, including rats whose SAE model had already been established. That is contrary to the claim that preclinical interventions are universally given prophylactically or within hours of insult. The mtDNA injection was an experimental challenge, not a therapeutic treatment; the paper does not establish the broader claim about clinical recognition or therapeutic windows. (LLM, conf=0.78)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [75] Fu, 2019, NLRP3/Caspase-1 Pathway-Induced Pyroptosis Mediated Cognitive Deficits in a Mouse Model of Sepsis-Associated Encephalopathy, Inflammation sourceExperimental — accuracy not yet measured
The Drug Administrations section reports that this mouse study first gave MCC950 or Ac-YVAD-CMK 30 minutes before surgery, supporting prophylactic initiation. It also reports doses on days 1, 2, 4, and 6 afterward. One study cannot establish that preclinical studies universally use prophylactic or within-hours administration. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Furthermore, species differences in microglial density, BBB tight junction composition, and cholinergic system organization between rodents and humans likely restrict direct extrapolation of preclinical findings to human patients [15,16,18].”
§ Research Advances in the Pathogenesis of Sepsis-Associated Encephalopathy > 4. Integrated Discussion and Critical Appraisal > 4.2. Critical Appraisal of Evidence and Unresolved Controversies
What the sources say
- Not checked — no full text of the sourcecites [15] Ronaldson, 2020, Regulation of blood-brain barrier integrity by microglia in health and disease: A therapeutic opportunity, J. Cereb. Blood Flow Metab. source
- Could not verifycites [16] Wang, 2022, Overexpression of Foxc1 ameliorates sepsis-associated encephalopathy by inhibiting microglial migration and neuroinflammation through the IκBα/NF-κB pathway, Mol. Med. Rep. sourceExperimental — accuracy not yet measured
The Materials and methods (Animals; page unavailable) describe a mouse study, and the Discussion (page unavailable) discusses microglia and BBB disruption. Neither passage compares rodents with humans or addresses microglial density, BBB tight-junction composition, cholinergic organization, or limits on extrapolation to patients. Searches for those terms and translational limitations found no supporting passage. (LLM, conf=0.75)
- Could not verifycites [18] Haruwaka, 2019, Dual microglia effects on blood brain barrier permeability induced by systemic inflammation, Nat. Commun. sourceExperimental — accuracy not yet measured
The Methods (Strains and animal care; page not provided) describe experiments in mice, and the Introduction discusses microglia and BBB tight-junction proteins. Our copy does not compare rodents with humans in microglial density, tight-junction composition, or cholinergic organization, or discuss how such differences affect clinical extrapolation (searched for those terms and human translation). (LLM, conf=0.76)
states a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
138 more claims · 100 with their cited sources checked
Create a free account to see all 194 claims and every source verdict.
- It may state two separate claims as one. 47
- Probably not a substantial claim. 7
- The quote only partly states this claim. 2
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Research Advances in the Pathogenesis of Sepsis-Associated Encephalopathy > 2. Materials and Methods
“Data were extracted and synthesized according to four core pathological components consistent with the review’s framework: neuroinflammatory storms, BBB remodeling, neurotransmitter network imbalances, and gut–brain axis dysregulation.”
§ Research Advances in the Pathogenesis of Sepsis-Associated Encephalopathy > 1. Introduction
“This review systematically examines and synthesizes current evidence on six core pathological components organized along four sequential axes (Figure 1):”
Citations
Cites
NLRP3 inflammasome activation and cell death
Huang, Y., Xu, W., & Zhou, R. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00740-6 · Cited by 1,527 · cited 1×
“Simultaneously, ROS produced within endothelial cells can oxida-tively damage TJ proteins and activate the NLRP3 inflammasome, leading to caspase-1 activation and IL-1 β maturation, exacerbating local disruption in an autocrine manner [48].”
The blood-brain barrier in systemic inflammation
Varatharaj, A., & Galea, I. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.03.010 · Cited by 1,172 · cited 2×
“The BBB is a sophisticated structure composed of brain microvascular endothelial cells (BMECs) with their tight junctions (TJ), basement membrane, astrocytic end-feet, and pericytes, serving as the critical defensive line for CNS homeostasis [44].”
Dual microglia effects on blood brain barrier permeability induced by systemic inflammation
Haruwaka, K., Ikegami, A., Tachibana, Y., Ohno, N., Konishi, H., Hashimoto, A., Matsumoto, M., Kato, D., Ono, R., Kiyama, H., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13812-z · Cited by 923 · cited 2×
“During sepsis, these cells undergo dynamic functional transformation: early activation exerts protective effects via Foxc1-mediated I κ B α /NF-κ B signaling regulation [16]; however, sustained activation triggered by the RAGE ligand S100B exacerbates abnormal BBB permeability [17,18].”
Sepsis-associated encephalopathy
Gofton, T. E., & Young, G. B. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.183 · Cited by 821 · cited 5×
“Sepsis-associated encephalopathy (SAE) occurs in more than 50% of hospitalized sepsis patients and is associated with high mortality [1].”
InfluentialRonaldson, P. T., & Davis, T. P. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20951995 · Cited by 392 · cited 2×
“Furthermore, species differences in microglial density, BBB tight junction composition, and cholinergic system organization between rodents and humans likely restrict direct extrapolation of preclinical findings to human patients [15,16,18].”
Superoxide Anion Chemistry—Its Role at the Core of the Innate Immunity
Andrés, C. M. C., Pérez de la Lastra, J. M., Andrés Juan, C., Plou, F. J., & Pérez-Lebeña, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031841 · Cited by 342
Sepsis-associated encephalopathy: A vicious cycle of immunosuppression
Ren, C., Yao, R.-Q., Zhang, H., Feng, Y.-W., & Yao, Y.-M. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-1701-3 · Cited by 259 · cited 1×
“In SAE, brain-infiltrating Tregs antagonize microglial inflammatory cascades by secreting factors like IL-10 and TGF-β , and suppress astrocytic IL-6 synthesis through the amphiregulin (AREG)-EGFR signaling axis [35,36].”
TNF-alpha-induced microglia activation requires miR-342: Impact on NF-kB signaling and neurotoxicity
Brás, J. P., Bravo, J., Freitas, J., Barbosa, M. A., Santos, S. G., Summavielle, T., & Almeida, M. I. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2626-6 · Cited by 236 · cited 1×
“In addition to the mitochondrial damage induced by TNF-α , TNF-α also induces excitotoxic neuronal injury by causing abnormal glutamate secretion from glial cells and inhibiting astrocytic reuptake [20].”
Fu, Q., Wu, J., Zhou, X.-Y., Ji, M.-H., Mao, Q.-H., Li, Q., Zong, M.-M., Zhou, Z.-Q., & Yang, J.-J. (2019) · Inflammation · doi:10.1007/s10753-018-0894-4 · Cited by 232 · cited 3×
“LPS injection produces rapid, transient neuroinflammation, whereas CLP induces polymicrobial sepsis with more sustained CNS pathology [3,75].”
Guo, S.-B., Meng, Y., Lin, L., Zhou, Z.-Z., Li, H.-L., Tian, X.-P., & Huang, W.-J. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02140-6 · Cited by 225 · cited 1×
“(5) Integrating AI-driven structural biology: AlphaFold-enabled protein structure prediction may accelerate rational design of BBB-penetrant agents targeting the core pathological axis [116].”
Metadata
- Authors
- Tan, H., Su, W., & Niu, Z.
- Affiliations
- Sichuan University (CN)
- Corresponding author
- Niu, Zhendong
- ORCID
- Tan, Haowen
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2026-06-15
- Volume
- 27
- Issue
- 12
- Pages
- 5390
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC13300322
- OpenAlex
- W7164863602
- Cited by
- 1
- References
- 116
- Citations by year
- 2026: 1
- FWCI
- 1.15
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Ministry of Science and Technology of the People’s Republic of China (STI2030-Major Projects2021ZD0201900)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Keywords
- sepsis-associated encephalopathy, neuroinflammation, pathogen-associated molecular patterns, damage-associated molecular patterns, microglia, regulatory T cells, neutrophils, blood-brain barrier disruption, tight junctions, programmed cell death, autophagy, apoptosis, pyroptosis, ferroptosis, mitochondrial dysfunction, glutamate excitotoxicity, cholinergic deficit, gut-brain axis, gut microbiota metabolites, butyrate, indolepropionic acid, microcirculatory disturbances
- MeSH terms
- Neuroinflammatory Diseases, Animals, Blood-Brain Barrier, Humans, Mitochondria, Sepsis, Sepsis-Associated Encephalopathy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Research Advances in the Pathogenesis of Sepsis-Associated Encephalopathy. https://app.cochat.ai/papers/10.3390/ijms27125390
- The paper
- Tan, H., Su, W., & Niu, Z. (2026). Research Advances in the Pathogenesis of Sepsis-Associated Encephalopathy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27125390
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.